RecruitingNCT06240559

In Vivo Treatment Verification of Brachytherapy

In-vivo Treatment Verification for HDR Brachytherapy Patients Using an External Imaging Panel


Sponsor

Maastricht Radiation Oncology

Enrollment

100 participants

Start Date

Feb 29, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

To acquire data during High Dose Rate (HDR) brachytherapy treatments aiming to track the brachytherapy source inside the patient verifying the delivery of the treatment plan. Medical images (CT,MRI and US) combined with software developed by the investigator will be employed to predict the response of the Investigational product during the treatment and will be used as reference.The IP will be placed on the side of the treatment table and will acquire data during the whole treatment, which will be compared against information derived from the treatment plan. The IP based method can detect errors and information about motion and treatment uncertainties that are not currently available.


Eligibility

Inclusion Criteria4

  • Treatment site Gynaecology (Endometrium/Cervix) and prostate
  • Treatment: HDR Brachytherapy
  • Patient will be treated on CT Couch
  • Mentally competent patient

Exclusion Criteria1

  • Incapacitated patient

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEExternal imaging panel

The IP will be placed on the side of the treatment table and will acquire data during the whole treatment, which will be compared against information derived from the treatment plan. The IP based method can detect errors and information about motion and treatment uncertainties that are not currently available.


Locations(1)

Maastro

Maastricht, Limburg, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06240559


Related Trials